Study of Oxaliplatin/5-FU/Leucovorin Plus Vatalanib Versus Oxaliplatin/5-FU/Leucovorin in Patients With Metastatic Colorectal Cancer.
Colorectal Neoplasms, Colonic Neoplasms, Rectal Neoplasms
About this trial
This is an interventional treatment trial for Colorectal Neoplasms focused on measuring Colorectal Cancer, PTK787, Vatalanib, VEGF inhibitor, Oxaliplatin, Angiogenesis, Rectal Cancer, Colon Cancer, Colorectal Carcinoma, Colorectal Tumor
Eligibility Criteria
Inclusion criteria: Patients with metastatic colorectal cancer coming for initial chemotherapy Documented metastatic colorectal cancer WHO Performance Status of 0, 1, or 2 Measurable tumors Adequate hematologic status, liver and kidney function Life expectancy greater than 12 weeks Written informed consent obtained Exclusion criteria: History or presence of central nervous system disease Patients with a history of another primary cancer within 5 years Prior chemotherapy for metastatic colorectal cancer Prior full field radiotherapy within 4 weeks or limited field radiotherapy within 2 weeks before entry to study Major surgery within 4 weeks or minor surgery within 2 weeks before entry to study Investigational drugs within 4 weeks before entry to study Prior therapy with anti-VEGF agents Any prior therapy with oxaliplatin or allergy to platinum-containing drugs Peripheral neuropathy with functional impairment Female patients who are pregnant or breast feeding Any severe or uncontrolled medical conditions which could prevent participation in study Patients who are taking Coumadin Other protocol-defined inclusion / exclusion criteria may apply
Sites / Locations
- Alabama Hematology/Oncology
- Palo Verde Hematology & Oncology
- Arizona Cancer Center
- Northeast Arkansas Clinic
- Highlands Oncology Group
- Comprehensive Blood and Cancer Center
- Providence St. Joseph Medical Center
- Compassionate Cancer Care Medical Group, Inc
- California Oncology of the Central Valley
- Virginia K. Crosson Cancer Center
- Ronald Yanagiharaa, M.D.
- Glendale Adventist Medical Center Cancer Center
- Pacific Shores Medical Group
- Cancer Institute Medical Group
- USC/Norris Comprehensive Cancer Care Center
- Synergy Hematology-Oncology Medical Associates
- UCLA School of Medicine
- Eddie Hong-Lung Hu, M.D.
- North Valley Hematology/Oncology Medical Group
- Ventura County Hematology-Oncology Specialists
- Wilshire Oncology Medical Group
- Sierra View District Hospital
- The Lucy Curci Cancer Center
- Cancer Care Associates Medical Group, Inc.
- Pacific Hematology Oncology Associates
- Santa Clara Valley Medical Center
- Sansum Santa Barbara Foundation Medical Clinic
- Santa Barbara Hematology Oncology Medical Group, Inc.
- San Diego Cancer Center Medical Group
- Colorado Cancer Research Program
- Jennifer Caskey, M.D.
- Davis, Posteraro and Wasser, MD's, LLP
- Connecticut Oncology Group
- Medical Oncology Hematology Consultants
- Washington Oncology-Hematology Center
- George Washington University Medical Center
- Boca Raton Comprehensive Cancer Center
- Florida Cancer Specialists
- Memorial Healthcare System
- Florida Oncology Associates
- Lakeland Regional Cancer Center
- Innovative Medical Research of South Florida
- Oncology Hematology Group of South Florida
- Hematology Oncology Associates of Treasure
- Florida Medical Clinic, PA
- Peachtree Hematology and Oncology
- Coastal Hematology & Oncology
- North Idaho Cancer Center
- Shelby D. Rifkin, M.D.
- Monroe Medical Associates
- Oncology Hematology Associates of Central Illinois, PC
- Northshore Cancer Research Association
- Midwest Cancer Research Group
- Hematology-Oncology of Indiana, PC
- Associated Physicians & Surgeons Clinic, L.L.C.
- Markey Clinical Oncology Research Program
- Norton Healthcare Pavilion
- Vijay Raghavan, M.D.
- Louisiana Oncology Associates
- LSU Medical Center
- Tulane University Health Sciences Center
- LSU Health Sciences Center
- Maine Center for Cancer Medicine & Blood Disorders
- St. Agnes Healthcare, Inc.
- Kaiser Permanente
- St. Joseph Mercy Hospital
- Josephine Ford Cancer Center
- Genesys Hurley Cancer Institute
- Spectrum Health -- Cook Research Dept.
- Hematology and Oncology Assoc. of Southern Mississippi
- Oncology Care Associates, PLLC
- Providence Cancer Center
- SMDC Health System
- Minnesota CGOP
- University of Minnesota Cancer Center
- Metro Minnesota CCOP
- Heartland Hematology/Oncology Associates, Inc.
- Kansas City Oncology and Hematology Group
- Missouri Cancer Care, PC
- Saint Louis University
- Washington University School of Medicine
- Missouri Baptist Cancer Center
- Arch Medical Services Incorporated
- North Central Montana Professional Building
- Montana Cancer Specialists
- The Methodist Cancer Center
- Comprehensive Cancer Centers of Nevada
- Nevada Cancer Center
- The Center for Cancer and Hematologic Disease
- St. Barnabas Cancer Center
- Hematology-Oncology Associates of New Jersey
- Southern Oncology and Hematology Associates
- Cooper Cancer Institute
- New Mexico Cancer Care
- Roswell Park Cancer Institute
- CR Wood Cancer Center
- Cancer Research of Long Island
- Broome Oncology
- New York Oncology Hematology
- North Shore University Hospital
- Cancer Center at Nyack Hospital
- Pluta Cancer Center
- Carolina Medical Center
- Mid-Dakota Clinic PC
- Nashat Gabrail, M.D.
- Mid Ohio Oncology/Hematology, Inc.
- Hematology Oncology Consultants, Inc.
- Meridia Cancer Institute
- Cancer Care Associates
- Cancer Care Associates
- Kaiser Permanente Oncology Hematology
- Hershey Medical Center
- Monogahela Valley Hospital
- University of Pennsylvania Abramson Cancer Center
- Allegheny Cancer Center
- Charleston Hematology Oncology
- Charleston Cancer Center
- South Carolina Oncology Associates
- Cancer Center of the Carolinas
- Spartanburg Regional Medical Center
- The Jones Clinic
- Baptist Regional Cancer Center
- University of Tennessee Cancer Institute
- Sarah Cannon Cancer Center
- Southwest Regional Cancer Center
- Corpus Christi Cancer Center
- Center for Oncology Research & Treatment, PA
- Oncology Consultants
- H. Alejandro Preti, MD, PA
- M.D. Anderson Cancer Center
- Dr. Lee C. Drinkard
- Scott & White Hospital
- North Utah Associates
- Utah Cancer Specialists
- Southwestern Vermont Health Care
- Danville Hematology and Oncology, Inc.
- Northern Virginia Oncology Group
- Virginia Oncology Associates
- Cancer Treatment Centers of America
- Virginia Cancer Institute
- Western Washington Medical Group
- Western Washington Medical Group
- Cascade Cancer Center
- UW Health -- University of Wisconsin Comp
- Waukesha Memorial Hospital
- Novartis Investigative Site
- Novartis Investigative Site
- Novartis Investigative Site
- Novartis Investigative Site
- Novartis Investigative Site
- Novartis Investigative Site
Arms of the Study
Arm 1
Arm 2
Experimental
Placebo Comparator
1
2
Oxaliplatin/5-FU/LV and PTK787/ZK 222584
Oxaliplatin/5-FU/LV and placebo